Aromatase inhibitors, arthralgias, and exercise in breast cancer survivors

被引：0
|
作者：
Irwin, Melinda
Cartmel, Brenda
Ercolano, Elizabeth
Fiellin, Martha
Rothbard, Marianna
Capozza, Scott
Zhou, Yang
Schmitz, Kathryn
Ligibel, Jennifer A.
Hershman, Dawn L.
Neogi, Tuhina
Gross, Cary P.
机构：
[1] Yale Univ, New Haven, CT USA
[2] Yale Univ, Sch Publ Hlth, New Haven, CT USA
[3] Univ Penn, Philadelphia, PA 19104 USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Columbia Univ, Med Ctr, New York, NY USA
[6] Boston Univ, Boston, MA 02215 USA
[7] Yale Univ, Sch Med, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS669
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Safety of prasterone in breast cancer survivors treated with aromatase inhibitors: the VIBRA pilot study
    Mension, E.
    Alonso, I
    Cebrecos, I
    Castrejon, N.
    Tortajada, M.
    Matas, I
    Gomez, S.
    Ribera, L.
    Angles-Acedo, S.
    Castelo-Branco, C.
    CLIMACTERIC, 2022, 25 (05) : 476 - 482
  • [42] Periodontal health in early-stage postmenopausal breast cancer survivors on aromatase inhibitors
    Taichman, L. Susan
    Inglehart, Marita
    Giannobile, William
    Braun, Thomas
    Kolenic, Giselle
    Van Poznak, Catherine
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors
    Kannie Chim
    Sharon X Xie
    Carrie T Stricker
    Qing S Li
    Robert Gross
    John T Farrar
    Angela DeMichele
    Jun J Mao
    BMC Cancer, 13
  • [44] Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors
    Chim, Kannie
    Xie, Sharon X.
    Stricker, Carrie T.
    Li, Qing S.
    Gross, Robert
    Farrar, John T.
    DeMichele, Angela
    Mao, Jun J.
    BMC CANCER, 2013, 13
  • [45] Ageing perceptions and non-adherence to aromatase inhibitors among breast cancer survivors
    Brier, Moriah J.
    Chambless, Dianne L.
    Chen, Jinbo
    Mao, Jun J.
    EUROPEAN JOURNAL OF CANCER, 2018, 91 : 145 - 152
  • [46] Perceived Barriers to Treatment Predict Adherence to Aromatase Inhibitors Among Breast Cancer Survivors
    Brier, Moriah J.
    Chambless, Dianne L.
    Gross, Robert
    Chen, Jinbo
    Mao, Jun J.
    CANCER, 2017, 123 (01) : 169 - 176
  • [47] Vaginal microbiomes of breast cancer survivors treated with aromatase inhibitors with and without vulvovaginal symptoms
    Prasanchit, Pimpun
    Pongchaikul, Pisut
    Lertsittichai, Panuwat
    Tantitham, Chananya
    Manonai, Jittima
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [48] Difrusion of aromatase inhibitors for breast cancer
    Aiello, Erin J.
    Geiger, Ann M.
    Pardee, Roy
    Buist, Diana S. M.
    Hart, Gene
    Greene, Sarah M.
    Lamerato, Lois
    Field, Terry
    Wagner, Ed
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S176 - S176
  • [49] Aromatase Inhibitors for Treatment of Breast Cancer
    Benson, John R.
    Ravisekar, Oduru
    CURRENT CANCER THERAPY REVIEWS, 2007, 3 (01) : 67 - 79
  • [50] Aromatase inhibitors and male breast cancer
    E. Arriola
    E. Hui
    M. Dowsett
    I. E. Smith
    Clinical and Translational Oncology, 2007, 9 : 192 - 194
12345